Want to see JP:5721 full AI Analyst Report?
S.Science Company, Ltd. (5721) Ratios
S.Science Company, Ltd. Ratios
JP:5721's free cash flow for Q2 2024 was $0.00. For the 2024 fiscal year, JP:5721's free cash flow was increased by $0.00 and operating cash flow was $0.00. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.39 | 87.53 | 21.54 | 11.30 | 15.95 |
| Quick Ratio | 2.23 | 70.66 | 17.13 | 7.86 | 12.14 |
| Cash Ratio | 1.61 | 65.39 | 9.78 | 6.29 | 10.29 |
| Solvency Ratio | -2.62 | -0.70 | 1.48 | -0.33 | -1.27 |
| Operating Cash Flow Ratio | 0.09 | -7.62 | -1.03 | -0.69 | -1.27 |
| Short-Term Operating Cash Flow Coverage | 0.11 | 0.00 | -49.91 | -47.47 | -71.65 |
| Net Current Asset Value | $ 1.26B | $ 2.78B | $ 2.86B | $ 2.02B | $ 2.44B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.13 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | 0.16 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Capital Ratio | 0.14 | 0.00 | 0.00 | 0.00 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.21 | 1.05 | 1.09 | 1.12 | 1.09 |
| Debt Service Coverage Ratio | -0.15 | 0.00 | 44.58 | -34.34 | -104.88 |
| Interest Coverage Ratio | -0.63 | 0.00 | -46.15 | -4341.56 | -9629.04 |
| Debt to Market Cap | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 6.25 | 0.00 | 0.07 | 0.02 | 0.03 |
| Net Debt to EBITDA | 5.12 | 7.49 | -3.22 | 13.68 | 5.56 |
| Profitability Margins | |||||
| Gross Profit Margin | 38.84% | 11.32% | 3.00% | 16.89% | 21.52% |
| EBIT Margin | -10.13% | -46.04% | 61.09% | -7.10% | -27.98% |
| EBITDA Margin | -10.12% | -45.82% | 61.28% | -6.99% | -26.95% |
| Operating Profit Margin | -10.13% | -46.04% | -43.35% | -8.62% | -22.50% |
| Pretax Profit Margin | -175.19% | -14.45% | 54.98% | -7.10% | -27.98% |
| Net Profit Margin | -175.50% | -15.25% | 54.19% | -7.75% | -28.50% |
| Continuous Operations Profit Margin | -175.50% | -15.25% | 54.19% | -7.75% | -28.50% |
| Net Income Per EBT | 100.18% | 105.51% | 98.56% | 109.22% | 101.87% |
| EBT Per EBIT | 1728.59% | 31.39% | -126.83% | 82.41% | 124.37% |
| Return on Assets (ROA) | -44.63% | -3.22% | 11.89% | -3.58% | -11.20% |
| Return on Equity (ROE) | -53.80% | -3.37% | 12.94% | -4.01% | -12.25% |
| Return on Capital Employed (ROCE) | -3.08% | -9.82% | -9.96% | -4.28% | -9.38% |
| Return on Invested Capital (ROIC) | -2.66% | -9.82% | -9.80% | -4.27% | -9.37% |
| Return on Tangible Assets | -99.90% | -3.22% | 11.90% | -3.58% | -11.20% |
| Earnings Yield | -14.97% | -0.38% | 11.46% | -2.98% | -7.42% |
| Efficiency Ratios | |||||
| Receivables Turnover | 9.64 | 3.90 | 3.45 | 6.02 | 4.37 |
| Payables Turnover | 53.83 | 63.44 | 8.06 | 8.62 | 9.90 |
| Inventory Turnover | 5.84 | 1.00 | 1.09 | 1.58 | 1.41 |
| Fixed Asset Turnover | 5.53 | 10.10 | 608.56 | 24.94 | 5.71 |
| Asset Turnover | 0.25 | 0.21 | 0.22 | 0.46 | 0.39 |
| Working Capital Turnover Ratio | 0.69 | 0.22 | 0.28 | 0.58 | 0.54 |
| Cash Conversion Cycle | 93.62 | 452.07 | 395.76 | 248.93 | 305.48 |
| Days of Sales Outstanding | 37.85 | 93.67 | 105.67 | 60.68 | 83.51 |
| Days of Inventory Outstanding | 62.55 | 364.16 | 335.36 | 230.57 | 258.83 |
| Days of Payables Outstanding | 6.78 | 5.75 | 45.27 | 42.32 | 36.86 |
| Operating Cycle | 100.40 | 457.82 | 441.03 | 291.25 | 342.34 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.51 | -1.15 | -1.06 | -1.01 | -1.79 |
| Free Cash Flow Per Share | -1.14 | -1.15 | -1.06 | -1.01 | -3.79 |
| Dividend Paid and CapEx Coverage Ratio | 0.31 | -281.57 | -623.91 | -371.84 | -0.90 |
| Capital Expenditure Coverage Ratio | 0.31 | -288.62 | -659.64 | -381.81 | -0.90 |
| Operating Cash Flow Coverage Ratio | 0.11 | 0.00 | -49.91 | -47.47 | -71.65 |
| Operating Cash Flow to Sales Ratio | 0.06 | -0.40 | -0.21 | -0.10 | -0.19 |
| Free Cash Flow Yield | -1.07% | -0.99% | -4.41% | -4.03% | -10.23% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -6.68 | -263.64 | 8.72 | -33.55 | -13.49 |
| Price-to-Sales (P/S) Ratio | 11.72 | 40.38 | 4.73 | 2.60 | 3.84 |
| Price-to-Book (P/B) Ratio | 3.59 | 8.92 | 1.13 | 1.35 | 1.65 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -93.57 | -100.74 | -22.66 | -24.79 | -9.77 |
| Price-to-Operating Cash Flow Ratio | 208.04 | -101.09 | -22.69 | -24.86 | -20.66 |
| Price-to-Earnings Growth (PEG) Ratio | -0.00 | 2.11 | -0.02 | 0.46 | -6.02 |
| Enterprise Value Multiple | -110.67 | -80.64 | 4.50 | -23.56 | -8.70 |
| Enterprise Value | 16.15B | 23.44B | 1.98B | 2.24B | 2.71B |
| EV to EBITDA | -110.67 | -80.64 | 4.50 | -23.56 | -8.70 |
| EV to Sales | 11.20 | 36.95 | 2.76 | 1.65 | 2.34 |
| EV to Free Cash Flow | -89.43 | -92.18 | -13.22 | -15.68 | -5.96 |
| EV to Operating Cash Flow | 198.84 | -92.50 | -13.24 | -15.72 | -12.61 |
| Tangible Book Value Per Share | 9.92 | 13.00 | 21.26 | 18.58 | 22.41 |
| Shareholders’ Equity Per Share | 29.78 | 13.00 | 21.26 | 18.58 | 22.41 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.00 | -0.06 | 0.01 | -0.09 | -0.02 |
| Revenue Per Share | 9.13 | 2.87 | 5.08 | 9.61 | 9.63 |
| Net Income Per Share | -16.02 | -0.44 | 2.75 | -0.75 | -2.74 |
| Tax Burden | 1.00 | 1.06 | 0.99 | 1.09 | 1.02 |
| Interest Burden | 17.29 | 0.31 | 0.90 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.49 | 0.57 | 0.07 | 0.04 | 0.05 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | -0.03 | 2.64 | -0.35 | 1.47 | 0.66 |
Currency in JPY
